Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: Relationship to T(H)1 and T(H)2 cytokine profile

Archives of Neurology

Volumn 57, Issue 7, 2000, Pages 1027-1032

  Schifitto, Giovanni ^a   McDermott, Michael P ^a,b   Evans, Thomas ^a   Fitzgerald, Theresa ^a   Schwimmer, Joshua ^a   Demeter, Lisa ^a   Kieburtz, Karl ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; PRASTERONE SULFATE;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL;

EID: 0033938776     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.7.1027     Document Type: Article

References (41)

1. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol. 1995;13:487-512.
2. Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 1993;33:429-436.
3. Tyor WR, Wesselingh SL, Griffin JW, et al. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy [review]. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 9:379-388.
4. Mossman TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. J Immunol. 1986;136:2348-2357.
5. + T cell clones. J Immunol. 1988;141: 849-855.
6. Madden KS, Moynihan JA, Brenner GJ, et al. Sympathetic nervous system modulation of the immune system, III: alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol. 1994; 49:77-87.
7. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo, II: dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol. 1990;20:793-802.
8. Mulder JW, JosFrissen PH, Krijnen P, et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis. 1992;165:413-418.
9. Jacobson MA, Fissaro RE, Galmarini M, et al. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis. 1991;164:864-868.
10. Craddock C, Pasvol G, Bull R, et al. Cardiorespiratory arrest and autonomic neuropathy in AIDS. Lancet. 1987;2:16-18,
11. Freeman R, Roberts MS, Friedman LS, et al. Autonomic function and human immuno-deficiency virus infection. Neurology. 1990;40:575-580.
12. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology. 1996;47:1247-1253.
13. Ewing D. Analysis of heart rate variability and other non-invasive test with special reference to diabetes mellitus. In: Bannister R, Mathias CJ, eds. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. New York, NY: Oxford University Press; 1992:312-333.
14. Mathias C, Bannister R. Investigation of autonomic disorders. In: Bannister R. Mathias CJ, eds. A Textbook of Clinical Disorders of the Autonomic Nervous System Autonomic Failure. New York, NY: Oxford University Press; 1992:255-290.
15. Kumar M, Morgan R, Szapocznik J, et al. Norephinephrine response in early HIV infection. J Acquir Immune Defic Syndr. 1991;4:782-786.
16. 2-Microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens. Immunology. 1979;36:47-54.
17. de Monte S, Gabuzda DH, Ho DD, et al. Peripheral neuropathy in the acquired immuno-deficiency syndrome. Ann Neurol. 1988;23:485-492.
18. Esiri MM, Morris CS, Millard PR. Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci. 1993;114:178-187.
19. Yoshioka M, Shapshak P, Srivastava AK, et al. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology. 1994;44:1120-1130.
20. Apostolski S, McAlarney T, Quattrini A, et al. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol. 1993;34:855-863.
21. Ader R, Felten DL, Cohen N. Psychoneuroimmunology. San Diego, Calif: Academic Press Inc; 1991.
22. Felten DL, Felten SY, Bellinger DL, et al. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev. 1987; 100:225-260.
23. Landmann R. Beta-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest. 1992;22(suppl):30-36.
24. Averill LE, Stein R, Kammer GM. Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway. Cell Immunol. 1988;115:88-99.
25. Van Oosterhout AJ, Nukamp FP. Effect of lymphokines on β-adrenoceptor function of human peripheral blood mononuclear cells. Br J Clin Pharmacol. 1990; 30:150S-152S.
26. H1 development by selective inhibition of interleukin 12. J Clin Invest. 1997;100:1513-1519.
27. Nokta MA, Pollard RB. Human immunodeficiency virus replication: modulation by cellular levels of cAMP. AIDS Res Hum Retroviruses. 1992;8:1255-1261.
28. Chelmicka-Schorr E, Checinski M, Arnason BGW. Chemical sympathectomy augments severity of experimental allergic encephalomyelitis. J Neuroimmunol. 1988; 17:347-350
29. Felten DL, Felten SY, Bellinger DL, et al. Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis. Eur J Clin Invest. 1992;22(suppl):37-41.
30. H0 cells. Science. 1994;265:244-248.
31. H2 predominance in HIV-infected individuals. Science. 1994;265:248-252.
32. Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993;91:759-765.
33. Loria RM, Inge TH, Cook SS, et al. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol. 1988;26: 301-314.
34. Yang J. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res Hum Retroviruses. 1993;8:747-754.
35. Suzuki T, Suzuki N, Daynes RA, et al. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol. 1991;61:202-211.
36. Clerici M, Bevilacqua M, Vago T, et al. An immunoendocrinological hypothesis of HIV infection. Lancet. 1994;343:1552-1553.
37. So YT, Holtzman DM, Abrams DI, et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome: prevalence and clinical features from a population-based survey. Arch Neurol. 1988;45:945-948.
38. Cornblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology. 1988;38:794-796.
39. Navia BA, Jordan BD, Price RW. The AIDS dementia complex, I: clinical features. Ann Neurol. 1986;19:517-524.
40. 2-microglobulin in HIV-1 dementia. Neurology. 1992;42:1707-1712.
41. Chehimi J, Starr SE, Frank I, et al. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J Exp Med. 1994;179:1361-1366.